Product Information

CARISOPRODOL 250 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.5565 per EA under NDC 65862069301. Its NADAC has been published 421 times since Aug 2, 2017.

FDA first approved this application on Aug 6, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CARISOPRODOL 250 MG TABLET

carisoprodol
$0.5565per EA
DEA Schedule CIV

Strength

250 mg/1

NDC

65862069301

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/20/2025

Active Ingredients

CARISOPRODOL

Approval Type

Generic (ANDA)

FDA Application

ANDA040792

FDA Approved

8/6/2009

TE Code

AB

On Market Since

11/8/2016

Pharmacological Classes

Centrally-mediated Muscle Relaxation
Muscle Relaxant

Price Statistics

The NADAC for CARISOPRODOL 250 MG TABLET has been published 421 times since Aug 2, 2017, and over the history we have for it it has declined 77.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5565 per EA
All-time high$2.5351 (Oct 11, 2017)
All-time low$0.4137 (Jul 17, 2024)
Median price$1.0043
Average price$1.0971
Largest weekly change+80.1% (Aug 17, 2022)
Weeks tracked421
Tracking sinceAug 2, 2017

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

+6.9%

5Y

-56.5%

All

-77.5%

Last surveyed Aug 20, 2025 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 29% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of CARISOPRODOL 250 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CARISOPRODOL 250 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.5565 per EA (NDC 65862069301), effective Aug 20, 2025.

How has the price of CARISOPRODOL 250 MG TABLET changed over time?

Over the history we have for it, the NADAC for CARISOPRODOL 250 MG TABLET has declined 77.5%. It has been tracked across 421 weekly CMS publications since Aug 2, 2017.

What are the highest and lowest recorded NADAC prices for CARISOPRODOL 250 MG TABLET?

Since Aug 2, 2017, the NADAC for CARISOPRODOL 250 MG TABLET has ranged from a low of $0.4137 (Jul 17, 2024) to a high of $2.5351 (Oct 11, 2017), with a median of $1.0043 per EA.

Are there cheaper alternatives to CARISOPRODOL 250 MG TABLET?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CARISOPRODOL 250 MG TABLET, is $0.3975 per EA — about 29% below CARISOPRODOL 250 MG TABLET.

Who manufactures CARISOPRODOL 250 MG TABLET?

CARISOPRODOL 250 MG TABLET (NDC 65862069301) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.